- Potential benefitImmediate expensing improves firm cash flow by allowing upfront deductions for R&D investments.
- Potential benefitHigher refundable credit caps increase refundable tax support available to startups and small firms.
- Potential benefitLonger startup eligibility and higher gross receipts thresholds broaden the pool eligible for credits.
American Innovation and Jobs Act
Read twice and referred to the Committee on Finance.
The bill, titled the American Innovation and Jobs Act, amends the Internal Revenue Code to (1) restore immediate expensing (current deduction) for research and experimental expenditures under section 174 (with an effective date back to amounts paid or incurred in taxable years beginning after December 31, 2021), (2) expand and phase up the cap and eligibility rules for the refundable research credit available to new and small businesses (section 41(h)), including raising the refundable cap over time and lengthening the startup eligibility window, and (3) change certain calculations and election rules for qualified small businesses’ research credits (including specified rate and averaging changes). Several conforming and technical amendments to sections 41, 280C, 3111, and related provisions are included.
Revenue impact vs. growth incentive: liberals stress offsets; conservatives prioritize tax relief.
Relative to its intended legislative type, this bill is a well-specified set of substantive amendments to the Internal Revenue Code that clearly defines legal mechanics and integrates with existing statutory provisions.
The bill, titled the American Innovation and Jobs Act, amends the Internal Revenue Code to (1) restore immediate expensing (current deduction) for research and experimental expenditures under section 174 (with an effective date back to amounts paid or incurred in taxable years beginning after December 31, 2021), (2) expand and phase up the cap and eligibility rules for the refundable research credit available to new and small businesses (section 41(h)), including raising the refundable cap over time and lengthening the startup eligibility window, and (3) change certain calculations and election rules for qualified small businesses’ research credits (including specified rate and averaging changes).
Several conforming and technical amendments to sections 41, 280C, 3111, and related provisions are included.
Some specific numeric changes (credit rates and thresholds) are embedded in cross-references to existing Code sections.
Pro-growth, low-controversy content gives political appeal, but substantial projected revenue loss, retroactivity, and technical complexity lower chances without offsets or inclusion in a larger bill.
Relative to its intended legislative type, this bill is a well-specified set of substantive amendments to the Internal Revenue Code that clearly defines legal mechanics and integrates with existing statutory provisions. It provides explicit statutory language, effective dates, and numerous conforming amendments needed to change tax treatment of research expenditures and credits.
Revenue impact vs. growth incentive: liberals stress offsets; conservatives prioritize tax relief.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesLarger immediate deductions and refundable credits likely reduce federal revenue and increase budget deficits.
- TaxpayersRetroactive application to 2022 taxable years creates administrative complexity for taxpayers and IRS guidance needs.
- Potential burdenHigher benefits could produce windfalls to profitable firms or entities with limited additional R&D activity.
Why the argument around this bill splits.
Revenue impact vs. growth incentive: liberals stress offsets; conservatives prioritize tax relief.
Generally favorable toward strengthening R&D incentives and supporting startups, but concerned about lost revenue and whether benefits flow to large firms.
Views the restoration of immediate expensing as pro-innovation, while wanting safeguards or offsets to protect social programs and equity.
Generally supportive of pro-growth, targeted tax fixes that encourage domestic R&D and startups, while cautious about fiscal cost and administrative complexity.
Sees the retroactive expensing fix as resolving a trade law/TCJA inconsistency, but wants cost estimates and oversight.
Favorable: a pro-business, pro-innovation package that restores immediate expensing for R&D and increases refundable credit access for startups.
Sees this as improving U.S. competitiveness and incentivizing private-sector investment.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Pro-growth, low-controversy content gives political appeal, but substantial projected revenue loss, retroactivity, and technical complexity lower chances without offsets or inclusion in a larger bill.
- No CBO/JCT score or official cost estimate included
- Whether Congress would identify offsets or pay-fors to cover revenue loss
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Revenue impact vs. growth incentive: liberals stress offsets; conservatives prioritize tax relief.
Pro-growth, low-controversy content gives political appeal, but substantial projected revenue loss, retroactivity, and technical complexity…
Relative to its intended legislative type, this bill is a well-specified set of substantive amendments to the Internal Revenue Code that clearly defines legal mechanics and integrates with existing statutory provisions.…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.